Evaluation of a Diphtheria and Tetanus PLGA Microencapsulated Vaccine Formulation without Stabilizers

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|6|3|297-304

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.6, Iss.3, 2009-07, pp. : 297-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced-Antigen, Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine, Adsorbed (Boostrix® US Formulation): A Viewpoint by Scott A. Halperin

By Halperin Scott A.  

Pediatric Drugs, Vol. 8, Iss. 3, 2006-01 ,pp. : 196-196

Adis International

Access to resources Recommend Favorite

Diphtheria-tetanus vaccine: Psoriasis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Diphtheria tetanus vaccine: Eosinophilic cellulitis in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1102, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Diphtheria, tetanus and pertussis vaccine: Erythema multiforme in an infant: case report

By  

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Diphtheria tetanus and pertussis vaccine: Neurological disorders in children: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1142, 2007-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite